Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for ST Elevation Myocardial Infarction

• Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
• Dapagliflozin in STEMI Randomized Clinical Trial
• Evolocumab in STEMI
• Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
• Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
• Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
• Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
• Safety and Efficacy Study of Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
• Effect of rhBNP on CMD in Patients With STEMI After PPCI
• PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
• Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
• Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
• 1-Year Follow-up of OPTIMA-5
• Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
• The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
• Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
• Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
• Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.
• Early Administration of Heparin at FMC for PPCI of STEMI Patients
• Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
• Rituximab in Patients With ST-elevation Myocardial Infarction
• Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
• Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility
• The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
• The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction
• Effect of Statin Preloading in STEMI in Improving PCI Outcomes
• Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
• Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
• Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
• Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
• The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction
• Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
• Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
• A Phase 2B Study of RUC-4 in Subjects With ST-elevation MI
• Study of Roxadustat in the Treatment of Acute Myocardial Infarction
• Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
• Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
• Role of Alprazolam in the Management of Acute Coronary Syndrome
• Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
• Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
• The EPIVER Randomized Controlled Trial
• Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention
• 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
• ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
• Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
• A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
• SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial
• Bivalirudin in Late PCI for Oatients With STEMI
• Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
• A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI
• A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
• Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
• Effect of Doxycycline on Cardiac Remodelling in STEMI Patients
• Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
• Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction
• Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI
• Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
• Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.
• Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
• Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
• Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
• Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
• Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan
• Intramyocardial Haemorrhage in Patients With Primary STEMI
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
• BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
• Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI
• Effect of Intravenous Metoprolol Combining RIC on Myocardial Protection in STEMI Patients
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI
• Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI
• Doxycycline to Protect Heart Muscle After Heart Attacks
• Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
• Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
• Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
• Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
• The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
• The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
• Adjunctive, Low-dose tPA in Primary PCI for STEMI
• Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
• Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
• Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
• Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
• Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
• Sonothrombolysis in Patients With STEMI
• Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study
• Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry
• Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
• Non Culprit Lesion Study
• Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
• Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
• Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
• Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients
• Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
• Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
• Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
• Acute Coronary Syndrome Sri Lanka Audit Project
• The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
• Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
• The Effect of IV Cangrelor and Oral Ticagrelor Study
• Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
• ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
• Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty
• NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
• Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
• Effects of Glucagon Like Peptide-1 on No-reflow
• Anfibatide Treatment in STEMI Patients
• Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
• A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor
• Efficacy and Safety on Prouk for STEMI Patients in China
• Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
• Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
• Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
• Antiplatelet Therapy After Cardiac Arrest
• Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction
• Pharmacological Effects of Crushing Prasugrel in STEMI Patients
• Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
• Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
• Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
• Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy
• Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
• OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)
• Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
• Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
• Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
• Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis
• Colchicine in ST-elevation Myocardial Infarction
• EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
• CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
• Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
• Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
• High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
• REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
• The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)
• On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
• Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
• Pharmacoinvasive Therapy With Prourokinase
• Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
• Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
• PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
• Controlled Level EVERolimus in Acute Coronary Syndromes
• How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
• Rapid Activity of Platelet Inhibitor Drugs Study
• Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction
• Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
• Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion
• Nitrites in Acute Myocardial Infarction
• Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
• A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
• Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)
• Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
• The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
• A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
• Metformin to Reduce Heart Failure After Myocardial Infarction
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
• Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
• Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
• Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
• IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction
• Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
• A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study
• Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)
• A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
• STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)
• Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
• Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance
• Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction
• Warfarin After Anterior ST-Elevation Myocardial Infarction
• Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
• A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks
• Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
• Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction
• Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
• REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
• Salvage: Postconditioning With Adenosine for STEMI
• Which Therapy for Acute Heart Attacks? (The WEST Study)